Saphenous vein interposition grafts in the microsurgical treatment of cerebral ischemia

D. S. Samson, B. L. Gewertz, C. W. Beyer, R. M. Hodosh

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Saphenous vein interposition grafts of varying lengths have been used in 25 extracranial-intracranial bypasses since 1974. Indications for operation included transient ischemic episodes (13 cases), prophylactic augmentation of middle cerebral artery (MCA) collateral flow prior to surgical treatment of intracranial aneurysm (four), and traumatic occlusion of cervical or intracranial internal carotid arteries (eight). Vein grafts to cortical branches of MCA originated from superficial temporal or occipital arteries in ten cases, common or external carotid arteries in ten, and subclavian or innominate vessels in five. Twenty-one patients have been followed up for a minimum of 12 months. Immediate patency rate was 84%; one late graft occlusion decreased overall patency to 80%. There was one operative mortality. Early technical problems, including donor-recipient size disparity, anastomotic distortion, and inappropriate graft routing, have been overcome by the use of 2-mm veins, the avoidance of hydrostatic dilation, and the construction of retroauricular tunnels. It is reasonable to assume that long-term patency of these reconstructions will parallel that of extracranial-intracranial bypasses using autologous arteries.

Original languageEnglish (US)
Pages (from-to)1578-1582
Number of pages5
JournalArchives of Surgery
Volume116
Issue number12
StatePublished - 1981

Fingerprint

Saphenous Vein
Brain Ischemia
Transplants
Middle Cerebral Artery
Veins
Arteries
External Carotid Artery
Common Carotid Artery
Intracranial Aneurysm
Internal Carotid Artery
Therapeutics
Dilatation
Tissue Donors
Mortality

ASJC Scopus subject areas

  • Surgery

Cite this

Samson, D. S., Gewertz, B. L., Beyer, C. W., & Hodosh, R. M. (1981). Saphenous vein interposition grafts in the microsurgical treatment of cerebral ischemia. Archives of Surgery, 116(12), 1578-1582.

Saphenous vein interposition grafts in the microsurgical treatment of cerebral ischemia. / Samson, D. S.; Gewertz, B. L.; Beyer, C. W.; Hodosh, R. M.

In: Archives of Surgery, Vol. 116, No. 12, 1981, p. 1578-1582.

Research output: Contribution to journalArticle

Samson, DS, Gewertz, BL, Beyer, CW & Hodosh, RM 1981, 'Saphenous vein interposition grafts in the microsurgical treatment of cerebral ischemia', Archives of Surgery, vol. 116, no. 12, pp. 1578-1582.
Samson DS, Gewertz BL, Beyer CW, Hodosh RM. Saphenous vein interposition grafts in the microsurgical treatment of cerebral ischemia. Archives of Surgery. 1981;116(12):1578-1582.
Samson, D. S. ; Gewertz, B. L. ; Beyer, C. W. ; Hodosh, R. M. / Saphenous vein interposition grafts in the microsurgical treatment of cerebral ischemia. In: Archives of Surgery. 1981 ; Vol. 116, No. 12. pp. 1578-1582.
@article{34a1e3e78899458aa3a114464acdb771,
title = "Saphenous vein interposition grafts in the microsurgical treatment of cerebral ischemia",
abstract = "Saphenous vein interposition grafts of varying lengths have been used in 25 extracranial-intracranial bypasses since 1974. Indications for operation included transient ischemic episodes (13 cases), prophylactic augmentation of middle cerebral artery (MCA) collateral flow prior to surgical treatment of intracranial aneurysm (four), and traumatic occlusion of cervical or intracranial internal carotid arteries (eight). Vein grafts to cortical branches of MCA originated from superficial temporal or occipital arteries in ten cases, common or external carotid arteries in ten, and subclavian or innominate vessels in five. Twenty-one patients have been followed up for a minimum of 12 months. Immediate patency rate was 84{\%}; one late graft occlusion decreased overall patency to 80{\%}. There was one operative mortality. Early technical problems, including donor-recipient size disparity, anastomotic distortion, and inappropriate graft routing, have been overcome by the use of 2-mm veins, the avoidance of hydrostatic dilation, and the construction of retroauricular tunnels. It is reasonable to assume that long-term patency of these reconstructions will parallel that of extracranial-intracranial bypasses using autologous arteries.",
author = "Samson, {D. S.} and Gewertz, {B. L.} and Beyer, {C. W.} and Hodosh, {R. M.}",
year = "1981",
language = "English (US)",
volume = "116",
pages = "1578--1582",
journal = "JAMA Surgery",
issn = "2168-6254",
publisher = "American Medical Association",
number = "12",

}

TY - JOUR

T1 - Saphenous vein interposition grafts in the microsurgical treatment of cerebral ischemia

AU - Samson, D. S.

AU - Gewertz, B. L.

AU - Beyer, C. W.

AU - Hodosh, R. M.

PY - 1981

Y1 - 1981

N2 - Saphenous vein interposition grafts of varying lengths have been used in 25 extracranial-intracranial bypasses since 1974. Indications for operation included transient ischemic episodes (13 cases), prophylactic augmentation of middle cerebral artery (MCA) collateral flow prior to surgical treatment of intracranial aneurysm (four), and traumatic occlusion of cervical or intracranial internal carotid arteries (eight). Vein grafts to cortical branches of MCA originated from superficial temporal or occipital arteries in ten cases, common or external carotid arteries in ten, and subclavian or innominate vessels in five. Twenty-one patients have been followed up for a minimum of 12 months. Immediate patency rate was 84%; one late graft occlusion decreased overall patency to 80%. There was one operative mortality. Early technical problems, including donor-recipient size disparity, anastomotic distortion, and inappropriate graft routing, have been overcome by the use of 2-mm veins, the avoidance of hydrostatic dilation, and the construction of retroauricular tunnels. It is reasonable to assume that long-term patency of these reconstructions will parallel that of extracranial-intracranial bypasses using autologous arteries.

AB - Saphenous vein interposition grafts of varying lengths have been used in 25 extracranial-intracranial bypasses since 1974. Indications for operation included transient ischemic episodes (13 cases), prophylactic augmentation of middle cerebral artery (MCA) collateral flow prior to surgical treatment of intracranial aneurysm (four), and traumatic occlusion of cervical or intracranial internal carotid arteries (eight). Vein grafts to cortical branches of MCA originated from superficial temporal or occipital arteries in ten cases, common or external carotid arteries in ten, and subclavian or innominate vessels in five. Twenty-one patients have been followed up for a minimum of 12 months. Immediate patency rate was 84%; one late graft occlusion decreased overall patency to 80%. There was one operative mortality. Early technical problems, including donor-recipient size disparity, anastomotic distortion, and inappropriate graft routing, have been overcome by the use of 2-mm veins, the avoidance of hydrostatic dilation, and the construction of retroauricular tunnels. It is reasonable to assume that long-term patency of these reconstructions will parallel that of extracranial-intracranial bypasses using autologous arteries.

UR - http://www.scopus.com/inward/record.url?scp=0019856557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019856557&partnerID=8YFLogxK

M3 - Article

C2 - 7032465

AN - SCOPUS:0019856557

VL - 116

SP - 1578

EP - 1582

JO - JAMA Surgery

JF - JAMA Surgery

SN - 2168-6254

IS - 12

ER -